SUBSCRIBE
SUBSCRIBE

BioMidwest

Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, Ohio & Wisconsin

BioMidwest is home to manufacturing facilities, biotech, pharma and medical device companies—and BioSpace!—making the heartland a thriving hub for industry.

Major universities in the area, including the University of Chicago and Northwestern University, contribute to the industry’s success to create powerful pipelines of talent in this region.

BioMidwest is also home to state membership associations including iBIO, Indiana Health Industry Forum, IowaBio, MichBio, Missouri Biotechnology Association, Bio Nebraska, Ohio Life Sciences and BioForward Wisconsin.

FEATURED COMPANIES
NEWS FROM BIOMIDWEST
BioMidwest
Research Roundup: Hormone Identified that Drives Diabetes and More
December 16, 2021
 · 
5 min read
 · 
Mark Terry
Courtesy of Getty Images
BioMidwest
Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
December 15, 2021
 · 
3 min read
 · 
Mark Terry
Courtesy of Abbvie Inc.
Drug Development
Notch Another Win for AbbVie’s Rinvoq, This Time in Psoriatic Arthritis
December 15, 2021
 · 
2 min read
 · 
Alex Keown
Courtesy of Sarah Silbiger/Getty Images
FDA
FDA Warns Medtronic About Inadequacies at Diabetes Device Facility
December 15, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
Load More
See the latest job opportunities in BioMidwest
SEARCH JOBS
Courtesy of JHVEPhoto/GettyImages
Drug Development
FDA Cites Safety Concerns Over Pfizer and Lilly’s Osteoarthritis Drug Tanezumab
A briefing document from the U.S. FDA cites critical safety concerns with Pfizer and Eli Lilly’s anti-NGF osteoarthritis drug tanezumab, despite the fact that clinical trials have demonstrated the agent can help patients with osteoarthritis.
March 22, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
2021 Biopharma Update on the Novel Coronavirus: March 23
March 22, 2021
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: March 15-19
March 19, 2021
 · 
6 min read
 · 
Mark Terry
Jonathan Weiss/Shutterstock
Business
Eli Lilly and Foghorn to Leverage Gene Traffic Control in Oncology
December 13, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
Drug Development
Clinical Catch-Up: December 6-10
December 10, 2021
 · 
14 min read
 · 
Mark Terry
Courtesy of Getty Photos
Business
Eli Lilly Focuses on Obesity and Diabetes with $1.5 Billion Deal
December 10, 2021
 · 
2 min read
 · 
Alex Keown
FDA
Lilly’s Monoclonal Antibody Combo Wins EUA for Patients Under Age 12
December 3, 2021
 · 
2 min read
 · 
Alex Keown
Load More
MORE COMPANIES IN BIOMIDWEST
Battelle
Cingulate Therapeutics
CMIC Inc
DiaMedica Therapeutics, Inc.
Elephas
Humanetics
ImmunoPhotonics
INCOG BioPharma Services
Medexus Pharma
Northstar Medical Radiosotopes
Odyssey Therapeutics
ONL Therapeutics
Perspective Therapeutics
Sudo Biosciences
TE Connectivity
Telix Pharmaceuticals
TerSera Therapeutics
BioCapital
Clinical Catch-Up: November 29-December 3
December 3, 2021
 · 
9 min read
 · 
Mark Terry
Courtesy of Yuriko Nakao/Getty Images
Business
Astellas Hopes to Improve Gene Therapy Safety with $1.6 Billion Dyno Deal
December 2, 2021
 · 
2 min read
 · 
Kate Goodwin
Talaris Staff, Company Courtesy
Drug Development
Talaris is Rapidly Expanding as it Speeds Toward a First BLA
November 29, 2021
 · 
7 min read
 · 
Heather McKenzie
BioCapital
Giving Thanks for Scientific Advances and COVID-19 Relief
November 24, 2021
 · 
6 min read
 · 
Heather McKenzie and Ellen Camacho
Load More
Interested in appearing on the Hotbed Maps?
Find out how your organization can be featured!
LEARN MORE